Molecular mechanisms: Immune molecule boosts brain size
Mice with elevated levels of the immune molecule interleukin-6 have abnormally large brains, according to a study published 23 August in the International Journal of Neuroscience.
![](https://www.thetransmitter.org/wp-content/uploads/image-archive/images/in-brief/121023-il6-ib.jpg)
Capacious cavity: Brain structures that contain cerebrospinal fluid (blue) are larger in mice with activated immune systems (top) than in controls (bottom).
Mice with elevated levels of the immune molecule interleukin-6 have abnormally large brains, according to a study published 23 August in the International Journal of Neuroscience1.
Epidemiological studies suggest that infection during pregnancy can affect the fetal brain. The placenta filters out infectious particles, making the mother’s immune molecules the most likely cause of the brain and behavior changes seen in her child. In particular, cytokines — molecules that send activating signals to immune cells — have been linked to brain abnormalities in the child.
The cytokine interleukin-6 (IL-6) is elevated in the brains and blood of people with autism. In mice, boosting IL-6 levels leads to anxiety and cognitive and social deficits, and injecting it into a pregnant mouse leads to social deficits in her pups. Conversely, an antibody that inactivates IL-6 improves autism-like behaviors in these pups2.
A study published in June showed that boosting the levels of IL-6 in mice changes the shape and length of dendritic spines, the signal-receiving branches of neurons3. In the new study, the same team looked at brain volume in these mice using magnetic resonance imaging.
Mice expressing excess IL-6 have brains that are 18 percent larger than those of controls, the study found. This is likely to be the result of enlarged lateral ventricles, brain structures that contain cerebrospinal fluid. The ventricles are about 15 times bigger than those in controls, deforming nearby brain regions such as the hippocampus and the corpus callosum.
Children with autism have atypically large heads, or macrocephaly, up to 4 years of age. The new study suggests that this could be the result of elevated cytokines, the researchers say.
References:
1: Wei H. et al. Int. J. Dev. Neurosci. 30, 554-559 (2012) PubMed
2: Smith S.E. et al. J. Neurosci. 27,10695-10702 (2007) PubMed
3: Wei H. et al. Biochim. Biophys. Acta 1822, 831-842 (2012) PubMed
Recommended reading
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
![Research image of astrocytes and microglia in mouse brains.](https://www.thetransmitter.org/wp-content/uploads/2024/08/1200-spotted-20240903-1024x683.webp)
X-chromosome genes; neurobiology of infant crying; MCHAT in preemies
![Illustration of a red pencil with a white eraser that is being used against a white sheet of paper.](https://www.thetransmitter.org/wp-content/uploads/2024/08/correction-1200-1024x692.webp)
Task swap prompts data do-over for autism auditory perception study
Explore more from The Transmitter
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
![Computer-generated illustration of a pencil.](https://www.thetransmitter.org/wp-content/uploads/2024/08/APpencil-1200-1024x692.webp)